It's not quite sink or swim time, but it's getting close. If you're not submitting electronic claims in compliance with the Health Information Portability and Accountability Act, then you'll likely be waiting quite a bit longer to get paid, says a Feb. 27 program transmittal (change request 2981) from the Centers for Medicare & Medicaid Services. CMS will tweak its HIPAA contingency plan to push providers to get in line "as soon as possible," the transmittal says. Effective July 1 - with an implementation date of July 6 - all claims received in pre-HIPAA format will be waiting at least 27 days for reimbursement, while those claims in compliance will be eligible for payment in half that time. The volume of Medicare electronic claims received in correct HIPAA format was up to 66.72 percent between Feb 9. and Feb.13, CMS reports. That's up from 57.6 percent the previous month. The contingency plan is at www.cms.hhs.gov/manuals/pm_trans/R114CP.pdf.
CIGNA currently offers a course on Group 2 support surfaces, and plans to add sessions on power mobility, enteral nutrition, progressive corrective action plans and other topics, according to CIGNA Medical Director Dr. Robert Hoover, Jr. Whether the ruling will set a precedent for other cases is still questionable, experts say. And Rotech has signed a three-year deal to furnish continuous positive airway pressure (CPAP) devices and related products for treating snoring and obstructive sleep apnea to Gentiva CareCentrix patients in 48 states. The contract is expected to generate more than $25 million in annual revenues, says Rotech President and CEO Philip L. Carter. Apria Healthcare Group Inc. announced it wasn't renewing its $45 million contract with Gentiva earlier this year (see Eli's HCW, Vol. XIII, No. 4, p. 31). The National Seating branch says it plans to build some of its wheelchair, scooter and other product business by taking clients away from HMS. Via Christi is hiring three qualified replacement workers "and will continue to include mobility services as part of the one-stop-shop convenience that we offer our customers," HMS President Darryl Graham told the Journal in a statement. Owner David Glancy expects Rx's home infusion revenues, $15 million in 2003, to grow 25 percent for the next half decade, the paper says. Glancy predicts Rx's respiratory business, which launched in 2003 after a non-compete agreement expired from a previous sale, will grow 100 percent a year from its first-year revenues of $200,000. Staffing shortages, especially for nurses and pharmacists, are the main limits on growth, Glancy told the Times. Rx plans to open a hospice and palliative care division next year, when another non-compete agreement expires.